Rule
Rio2 Announces Upsize of Private Placement Up to C$23 Million
VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- Rio2 Limited (“Rio2” or the “Company”) (TSXV: RIO; OTCQX: RIOFF; BVL: RIO) is pleased to announce that further to the news release dated April 8, 2024, it has entered into an amending agreement with Eight Capital, as agent, to upsize the previously announced private placement. Pursuant to the upsized offering, the Company will issue up to 59,030,000 common shares of the Company (the “Shares”) at a price of $0.39 per Share (the “Offering Price”) for gross proceeds to the Company of up to $23,021,700 (the “Offering”).
- Alex Black, Executive Chairman, stated: “The Company received significant interest from key existing shareholders to participate in financing our Company at this stage of its development, far exceeding the $10 million maximum amount first announced.
- The LIFE Shares issued to Canadian resident subscribers in the Offering will not be subject to a hold period pursuant to applicable Canadian securities laws.
- The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the “U.S.
- Securities Act”) or under any U.S. state securities laws, and may not be offered or sold in the United States or to “U.S.
Rio2 Announces Receipt of RCA Resolution for the Fenix Gold Project & C$10 Million Private Placement
VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Rio2 Limited (“Rio2” or the “Company”) (TSXV: RIO; OTCQX: RIOFF; BVL: RIO) today announces that its Chilean subsidiary, Fenix Gold Limitada (“Fenix Gold”), has received the formal Resolución de Calificación Ambiental (Environmental Qualification Resolution, or RCA) for its Fenix Gold Project (the “Project”) located in the Maricunga Mineral Belt of the Atacama Region, Chile.
- The RCA has been issued following the approval of the Project’s Environmental Impact Assessment previously announced on December 20, 2023.
- The receipt of the RCA now allows Fenix Gold to advance permitting activities for the Project.
- The current timing for receipt of these principal permits is by the end of July 2024.
- The Company is seeking to finance a substantial component of the initial capital costs by way of Project related debt.
NeuBase Therapeutics Announces Receipt of Notice from Nasdaq
This Notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Capital Market.
- This Notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Capital Market.
- Under Nasdaq rules, the Company has 60 calendar days from receipt of the Notice, or until June 3, 2024, to submit a plan to regain compliance with the Rule.
- These forward-looking statements include, without limitation, statements relating to our continued listing on Nasdaq and any exception that may be granted by Nasdaq.
- Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements.
Pixalate’s Children’s Privacy Index for Mobile Advertising Sellers: February 2024
LONDON, April 04, 2024 (GLOBE NEWSWIRE) -- Pixalate , the global market-leading fraud protection, privacy, and compliance analytics platform for Connected TV (CTV) and Mobile Advertising, released the February 2024 Children’s Privacy Index for Mobile Advertising.
- LONDON, April 04, 2024 (GLOBE NEWSWIRE) -- Pixalate , the global market-leading fraud protection, privacy, and compliance analytics platform for Connected TV (CTV) and Mobile Advertising, released the February 2024 Children’s Privacy Index for Mobile Advertising.
- February 2024 COPPA Seller Trust Index Key Findings:
10 sellers received a High risk level. - Visit Pixalate’s Knowledge Base for more information about the Children’s Privacy Index for Mobile Advertising.
- Doing so would not only help parents protect their children online, but would also enable ad tech companies in complying with COPPA.
Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million
We are also pleased to announce our authorized share repurchase program, and our agreed repurchase of all shares owned by Sumitomo Pharma.
- We are also pleased to announce our authorized share repurchase program, and our agreed repurchase of all shares owned by Sumitomo Pharma.
- The NEPTUNE study enrolled 26 subjects with active NIU who were randomized 2:1 to brepocitinib 45 mg once daily or brepocitinib 15 mg once daily.
- All week 24 secondary efficacy endpoints, including haze grades, visual acuity, and macular thickness, were also positive and dose responsive.
- The presentation and webcast details are also available under “Events & Presentations” in the Investors section of the Roivant website at https://investor.roivant.com/news-events/events.
Oxbridge Re Announces Launch of Tokenized Real-World Asset Offering EpilsonCat Re
The Participation Shares will be offered at an initial price of $10 per Participation Share.
- The Participation Shares will be offered at an initial price of $10 per Participation Share.
- The Participation Shares are not shares in SurancePlus and shall have no preemptive right or conversion rights.
- Investors in last year’s DeltaCat Re token are poised to realize returns exceeding 45%, surpassing our initial expectations of 42%.
- Concurrently, we witness the steady adoption of blockchain technology across traditional financial institutions and asset classes, including fiat currencies, equities, government bonds, and real estate.
Hapbee Announces Closing of Private Placement
VANCOUVER, British Columbia, March 26, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies , Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), the digital wellness technology company is pleased to announce that it has completed a non-brokered private placement of units of the Company (“Units”) for aggregate gross proceeds to the Company of CAD$2,785,000 (the “Offering”).
- VANCOUVER, British Columbia, March 26, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies , Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), the digital wellness technology company is pleased to announce that it has completed a non-brokered private placement of units of the Company (“Units”) for aggregate gross proceeds to the Company of CAD$2,785,000 (the “Offering”).
- “This capital enables us to continue to evolve our products and to expand our market presence and manufacturing,” said Yona Shtern, CEO and Executive Chairman of Hapbee.
- The Company is also delighted to welcome Jaylen Brown who will join Hapbee as Chief Innovation Officer and Rizwan Shah who will join as Chief Commercial Officer.
- The securities offered pursuant to the Offering have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S.
Luna Innovations Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
This Notice has no immediate effect on the listing of the Company's shares on Nasdaq.
- This Notice has no immediate effect on the listing of the Company's shares on Nasdaq.
- However, if the Company fails to timely regain compliance with the Rule, the Company's common stock will be subject to delisting from Nasdaq.
- The Notice provides that the Company has 60 calendar days, or until June 30, 2024, to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rule.
- The Company is working diligently to complete its Form 10-K and will provide an update once more information is available.
Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
The Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the “SEC”).
- The Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the “SEC”).
- Under Nasdaq rules, the company has 60 calendar days from the receipt of the Notice, or until May 20, 2024, to submit a plan to regain compliance with the Rule.
- The company intends to file the Form 10-Q as promptly as reasonably practicable.
- If the company does not file the Form 10-Q by May 20, 2024, the company intends to timely submit a plan to regain compliance with the Rule.